Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.6663
+0.00590.89%
Post-market: 0.6600-0.0063-0.95%19:46 EDT
Volume:199.74K
Turnover:133.08K
Market Cap:4.80M
PE:-0.59
High:0.6840
Open:0.6745
Low:0.6600
Close:0.6604
Loading ...
Sep 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 20, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 15, 2022

Major Issues Report

8-K - Current report
Sep 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 29, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 01, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2022

Major Issues Report

8-K - Current report
Mar 07, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Major Issues Report

8-K - Current report
Dec 07, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2021

Major Issues Report

8-K - Current report
Sep 27, 2021

Major Issues Report

8-K - Current report
Aug 18, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2021

Major Issues Report

8-K - Current report